With ever increasing costs of gaining marketing authorisations for new drugs, fewer opportunities for blockbuster products and ongoing pressure on pricing, operating successfully in the pharmaceutical sector can be challenging. Our sector-focused team, many of whom have technical backgrounds, are able to help clients overcome these challenges and maximise the commercial opportunities.
Operating in one of the most highly regulated sectors, you need lawyers who are leaders in their field. We have expertise in the regulation of medicines, clinical trials, promotion and marketing, anti-corruption and industry codes, IP, data protection, competition, public procurement, tax and transfer pricing.
Whether you are looking to acquire a developmental pipeline from another company or streamline your own pipeline/portfolio to focus on particular therapeutic areas, we have relevant experience advising on product acquisition and disposal, R&D collaboration, supply chain, and licensing agreements. Having acted on large cross-border licensing and M&A deals for our sector-leading clients, our multi-disciplinary team can advise on transactions of any size and complexity.
We also represent clients in domestic and cross-border litigation, whether relating to commercial disputes, defence of product liability claims, protecting intellectual property rights or judicial review and public procurement challenges.